Conversely, Grem1, a BMP antagonist, was upregulated in Tnfaip6-deficient mMSCs, in line with its known inhibitory role in osteoblastogenesis and association with osteopenia (55–57). The gene discussed is TNFAIP6; the disease is Osteopenia.